Table 1 Demographics of the women screened
Characteristic | Number screened | Triaged positive | Number followed up | Cancer detected | PPVa |
|---|---|---|---|---|---|
Age | |||||
<30 | 878 [5.8%] | 66 [7.5%] | 39 [59.1%] | 1 | 2.6% |
30–40 | 6548 [43.5%] | 210 [3.2%] | 127 [60.5%] | 5 | 3.9% |
41–50 | 4374 [29.0%] | 84 [1.9%] | 43 [51.1%] | 4 | 9.3% |
51–60 | 2419 [16.1%] | 46 [1.9%] | 27 [56.7%] | 6 | 22.2% |
61–70 | 729 [4.8%] | 43 [5.9%] | 29 [67.4%] | 10 | 34.4% |
>71 | 121 [0.8%] | 11 [9.1%] | 3 [27.2%] | 1 | 33.3% |
Total | 15,069 | 460 [3.1%] | 268 [58.3%] | 27 | 10.1% |
Menopausal status | |||||
Pre –menopause | 9732 [64.6%] | 330 [3.4%] | 195 [59.1%] | 8 | 4.1% |
Post –menopause | 5337 [35.4%] | 130 [2.4%] | 73 [56.2%] | 19 | 26.0% |
Symptomatic status | |||||
Asymptomatic | 10531 [69.9%] | 108 [1.0%] | 47 [43.5%] | 2 | 4.3% |
Symptomatic | |||||
Complaint of breast swelling | 1557 [34.3%] | 304 [19.5%] | 192 [63.2%] | 25 | 13.0% |
Breast pain | 2934 [64.7%] | 123 [4.2%] | 80 [65.0%] | 9 | 11.3% |
Nipple discharge | 204 [4.5%] | 19 [9.3%] | 16 [84.2%] | 0 | – |
Non-specific complaints | 412 [9.1%] | 29 [7.0%] | 19 [65.5%] | 0 | – |
Post-mastectomy asymptomatic | 106 [2.3%] | 0 | 0 | 0 | – |
Post-mastectomy: symptomatic | 23 [0.5%] | 1 [4.3%] | 1 [100%] | 1 | 100% |
Post-lumpectomy: asymptomatic | 149 [3.3%] | 5 [3.4%] | 0 | 0 | – |
Post-lumpectomy symptomatic | 186 [4.1%] | 17 [9.1%] | 13 [76.5%] | 2 | 15.4% |
Symptomatic | 4538 [30.1%] | 352 [7.8%] | 221 [62.8%] | 25 | 11.3% |
